FDA pharmacologic class
Lipoglycopeptide Antibacterial
3 medicines are in FDA's class of lipoglycopeptide antibacterials: dalbavancin (Dalvance), oritavancin (Orbactiv) and telavancin (Vibativ). 1 of the 3 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are lipoglycopeptide antibacterial?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Dalbavancin | Dalvance | 6 labelers | n/a | No | No current entry | 0 |
| Oritavancin | Kimyrsa, Orbactiv | none listed | n/a | No | No current entry | 0 |
| Telavancin | Vibativ | none listed | n/a | Yes | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)